Maintenance of prolactin receptors in human breast cancer.
Breast tissue specimens of 110 women with various stages of breast cancer were tested in vitro to determine their specific binding sites for human prolactin. In contrast to the case of steroid receptors, binding sites for prolactin were found in the vast majority of breast cancer tissue. Distribution profiles giving amount of prolactin receptor and their affinity coefficients were found to be similar in the tissues of women whose ages, hormonal status, or stage of breast cancer varied. These findings show that in contrast to steroid receptors, human breast cancer tissue maintains binding sites for prolactin. The findings also indicate that there may be a higher dependency of breast cancer on prolactin than on steroids. Clinical trials must be carried out to determine the role of "positive" prolactin receptors in prognosis and prediction of response to future hormone therapy.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000378:metabolism*; D005260:Female; D006728:Hormones / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008593:Menopause; D008875:Middle Aged; D011956:Receptors, Cell Surface / Q000032:analysis / Q000378:metabolism*; D011981:Receptors, Prolactin
D006728:Hormones; D011956:Receptors, Cell Surface; D011981:Receptors, Prolactin